Mortality Trend in Patients With Heart Failure and Psychoactive Substance Abuse in the United States-Pre- and Post-COVID-19 Pandemic Perspective (1999-2023).

Authors

Emad Uddin Sajid, Ayesha Irfan, Muhammad Kashan, Syed Rayyan Ahmed, Muhammad Hasnain Azeem, Tooba Ali, Mabel Waqar, Muneeba Khan, Erum Shahzadi Malik, Md Ariful Haque

Published in

Clinical cardiology. Volume 49. Issue 8. Pages e70425.

Abstract

This study evaluates national trends in heart failure (HF) and psychoactive substance abuse-related mortality among adults aged 25 years and older in the United States (US) from 1999 to 2023, stratified by sex, age, race/ethnicity, geographic regions, and the COVID-19 pandemic period.
Data from 1999 to 2023 were extracted from the CDC WONDER database. Age-adjusted mortality rates (AAMR) and annual percentage changes (APC) were calculated using Joinpoint regression. ICD-10 codes I50, I50.1, I50.9 (Heart Failure), and F10-19 (Psychoactive Substance Use) were used to identify the conditions.
A total of 771 739 deaths were recorded from 1999 to 2023 among individuals aged 25 and older. Most deaths occurred in medical facilities (39.24%), followed by decedents' homes (34.14%), long-term care facilities (16.30%), hospice (6.65%), and other settings (3.67%). The AAMR increased markedly from 1.68 in 1999 to 20.7 in 2023 (AAPC of 12.09, 95% confidence interval [CI]: 10.97-14.26). A substantial increase was observed from 1999 to 2005 (APC: 38.5%, 95% CI: 29.1-55.8), followed by a slower increase until 2020 (APC: 5.68%, 95% CI: 5.02-14.8). Men showed consistently higher AAMRs than females (18.8 vs. 8.65). By age group, mortality was highest among individuals aged 65 years and older.
Using CDC WONDER data (1999-2023), we found a sharp rise in HF mortality linked to psychoactive substance abuse, from 1.68 to 20.7 per 100 000. Mortality burden was highest among males, older adults, non-Hispanic White individuals, and rural populations, highlighting widening demographic and geographic disparities.

PMID:
42507675
Bibliographic data and abstract were imported from PubMed on 28 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.